106
Participants
Start Date
June 6, 2012
Primary Completion Date
March 19, 2016
Study Completion Date
July 26, 2018
sunitinib
Sunitinib capsules will be given orally at continuous daily dosing with a starting dose of 37.5 mg. One cycle is equal to 28 days.
Semmelweis Egyetem/II. Sz. Belgyogyaszati Klinika, Budapest
Cliniques Universitaires Saint-Luc, Gastroenterologie, Brussels
Wits Clinical Research, Johannesburg
Barwon Health - University Hospital Geelong, Geelong
Columbia University Medical Center, New York
IEO Istituto Europeo di Oncologia, IRCCS, Milan
Hospital Universitario Madrid Sanchinarro - Centro Integral Oncológico Clara Campal (CIOCC), Madrid
Hôpital Beaujon, Clichy
Univeristy of California, Orange
China-Japan Friendship Hospital, Beijing
307 Hospital of PLA, Beijing
Beijing Cancer Hospital, Beijing
Fudan University Shanghai Cancer Center, Shanghai
Zhongshan Hospital Fudan University, Shanghai
Centrul de Oncologie Sf. Nectarie, Craiova
Nanjing Bayi Hospital, Nanjing
Tata Memorial Hospital, Mumbai
West China Hospital of Sichuan University, Chengdu
Masarykuv onkologicky ustav, Brno
Fakultni poliklinika, Prague
Vseobecna Fakultni Nemocnice v Praze, Prague
Kyushu University Hospital, Fukuoka
National Cancer Center Hospital, Chuo-ku
Oslo Universitetssykehus HF, Rikshospitalet, Oslo
Institutul Clinic Fundeni, Centrul de Gastroenterologie si Hepatologie, Bucharest
Narodny Onkologicky ustav, Bratislava
Lead Sponsor
Pfizer
INDUSTRY